Literature DB >> 7738729

Efficacy of AmBisome in murine coccidioidomycosis.

M M Albert1, K Adams, M J Luther, S H Sun, J R Graybill.   

Abstract

ICR mice were infected intranasally with arthroconidia of Coccicioides immitis. Mice were treated intravenously with amphotericin B deoxycholate (Fungizone) or an amphotericin B-lipid vehicle (AmBisome). Doses ranged from 0.05 to 1.0 mg kg-1. Lung weight, which parallels disease severity and fungal burden in this infection, was used as the index of protection. Both Fungizone and AmBisome were significantly and equally protective at 0.3 and 1.0 mg kg-1 body weight.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7738729     DOI: 10.1080/02681219480000621

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  6 in total

Review 1.  Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.

Authors:  A J Coukell; R N Brogden
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

Review 2.  Extended Dosing Regimens for Fungal Prophylaxis.

Authors:  Thomas Lehrnbecher; Konrad Bochennek; Thomas Klingebiel; Silke Gastine; Georg Hempel; Andreas H Groll
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

3.  Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.

Authors:  Karl V Clemons; Raymond A Sobel; Paul L Williams; Demosthenes Pappagianis; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

4.  Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.

Authors:  Gloria M González; Rolando Tijerina; Laura K Najvar; Rosie Bocanegra; Michael G Rinaldi; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 5.  Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.

Authors:  Neil R H Stone; Tihana Bicanic; Rahuman Salim; William Hope
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

Review 6.  The Rise of Coccidioides: Forces Against the Dust Devil Unleashed.

Authors:  Marley C Caballero Van Dyke; George R Thompson; John N Galgiani; Bridget M Barker
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.